Publication:
Frequency of ovarian endometriosis in epithelial ovarian cancer patients

dc.contributor.authorDzatic-Smiljkovic, O. (54986368200)
dc.contributor.authorVasiljevic, M. (6603666911)
dc.contributor.authorDjukic, M. (57208476700)
dc.contributor.authorVugdelic, R. (54986367300)
dc.contributor.authorVugdelic, J. (54989880000)
dc.date.accessioned2025-06-12T22:27:45Z
dc.date.available2025-06-12T22:27:45Z
dc.date.issued2011
dc.description.abstractPurpose: The aim of this study was to determine the frequency of endometriosis in epithelial ovarian cancer patients. Methods: Patients who had undergone epithelial ovarian cancer surgery between 2000 and 2004 were subjected to a retrospective analysis. The analysis focused on the presence of ovarian endometriosis, histological types and stages of ovarian cancer, treatment types and five-year survival rate. Results: Out of the 210 operated ovarian cancer patients, 23 had coexisting ovarian endometriosis. Ovarian endometriosis was detected in 3.5% (4 of 113 patients) of cases with serous ovarian cancer, in 31.6% ( 12 of 38 patients) of cases with endometrioid, and in 36.8% (7 of 19 patients) of cases with clear cell ovarian cancer. The treatment of ovarian cancer patients was a combination of surgery and chemotherapy. Conclusion: Endometriosis was most frequently present in patients with clear cell (36.8%) and endometrioid ovarian cancers (31.6%). The five-year survival rate for ovarian cancer patients in all stages was 39.1%.
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84857005037&partnerID=40&md5=cd8d18dfc06e8a74c7a13baaf5d5318a
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/9922
dc.subjectChemotherapy
dc.subjectClear cell ovarian cancer
dc.subjectEndometrioid ovarian cancer
dc.subjectEndometriosis
dc.subjectOvarian cancer
dc.subjectSerous ovarian cancer
dc.subjectSurgery
dc.titleFrequency of ovarian endometriosis in epithelial ovarian cancer patients
dspace.entity.typePublication

Files